NCT05693311

Brief Summary

The main purpose of this research is to identify incidence of jiunt manifestations by its both types axial and periphral in IBD patients, its types , relation to IBD activity, lines of treatment using and how they are effective in prevention and in treatment of these joint manifestations.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
217

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 24, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 20, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

January 20, 2023

Status Verified

January 1, 2023

Enrollment Period

1.8 years

First QC Date

December 24, 2022

Last Update Submit

January 12, 2023

Conditions

Keywords

IBDperiphral and axial spondylopathy

Outcome Measures

Primary Outcomes (1)

  • The joint manifestations in Inflammatory bowel disease patients.

    The main purpose of this research is to identify incidence of joint manifestations by its both types axial and peripheral in crohns disease and ulcerative colitis patients, relation to the disease activity,other extra intestinal manifestations, lines of treatment used and how they are effective in prevention and in treatment of these joint manifestations.

    2017 to 2024

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with inflammatory bowel disease attending IBD clinic in EL-RAGHY LIVERHOSPITAL.

You may qualify if:

  • Patients previously diagnosed by colonoscopy and biopsy of IBD either crhons disease or ulcerative colitis from2017 to 2022 attending IBD clinic in EL-RAGHY LIVERHOSPITAL.

You may not qualify if:

  • Patients with a known diagnosis of any other joint disease like:
  • autoimmune disease like SLE , RA , psoriasis
  • Osteoarthritis
  • Gouty arthritis
  • Malignancy
  • Polymyalgia rheumatica

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Voulgari PV. Rheumatological manifestations in inflammatory bowel disease. Ann Gastroenterol. 2011;24(3):173-180.

    PMID: 24713717BACKGROUND
  • Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World J Gastroenterol. 2019 May 14;25(18):2162-2176. doi: 10.3748/wjg.v25.i18.2162.

    PMID: 31143068BACKGROUND
  • Di Carlo M, Luchetti MM, Benfaremo D, Di Donato E, Mosca P, Maltoni S, Benedetti A, Gabrielli A, Grassi W, Salaffi F. The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis. Clin Rheumatol. 2018 Apr;37(4):1037-1044. doi: 10.1007/s10067-017-3937-6. Epub 2017 Dec 4.

    PMID: 29204760BACKGROUND

MeSH Terms

Conditions

Joint Diseases

Condition Hierarchy (Ancestors)

Musculoskeletal Diseases

Study Officials

  • Mohamed Ali, ass.prof doc

    assiut univeristy

    STUDY DIRECTOR

Central Study Contacts

Youstina soliman, doctor

CONTACT

nabawia tawfik, prof doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

December 24, 2022

First Posted

January 20, 2023

Study Start

March 1, 2023

Primary Completion

December 31, 2024

Study Completion

March 1, 2025

Last Updated

January 20, 2023

Record last verified: 2023-01